Laizer Kornwasser, EVP, Company Group Chairman at Valeant Pharmaceuticals International, Inc. (VRX), bought 2,536 shares at $132.15 ($335K) on 2014-01-24, disclosed to the SEC on 2014-01-28.
Scheduled purchase ($335k) by EVP, Company Group Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TDOC | SELL | 2024-05-02 | $264K | — | Filing → |
| TDOC | SELL | 2024-03-05 | $533K | — | Filing → |
| TDOC | SELL | 2024-02-02 | $302K | — | Filing → |